222 related articles for article (PubMed ID: 31179511)
1. Neurochondrin Antibody Serum Positivity in Three Cases of Autoimmune Cerebellar Ataxia.
Weihua Z; Haitao R; Fang F; Xunzhe Y; Jing W; Hongzhi G
Cerebellum; 2019 Dec; 18(6):1137-1142. PubMed ID: 31179511
[TBL] [Abstract][Full Text] [Related]
2. Anti-Tr/DNER antibody-associated cerebellar ataxia: three rare cases report and literature review.
Cai Y; Liu J; Ren H; Shi F; Che J; Geng Q; Tan Y; Guan H; Di W
Neurol Sci; 2023 Jan; 44(1):397-403. PubMed ID: 36094774
[TBL] [Abstract][Full Text] [Related]
3. Neurological Autoimmunity Associated With Homer-3 Antibody: A Case Series From China.
Liu M; Ren H; Fan S; Zhang W; Xu Y; Zhao W; Guan H;
Neurol Neuroimmunol Neuroinflamm; 2021 Nov; 8(6):. PubMed ID: 34580182
[TBL] [Abstract][Full Text] [Related]
4. Responses to and Outcomes of Treatment of Autoimmune Cerebellar Ataxia in Adults.
Jones AL; Flanagan EP; Pittock SJ; Mandrekar JN; Eggers SD; Ahlskog JE; McKeon A
JAMA Neurol; 2015 Nov; 72(11):1304-12. PubMed ID: 26414229
[TBL] [Abstract][Full Text] [Related]
5. Anti-Homer-3 antibody associated cerebellar ataxia: A rare case report and literature review.
Xu X; Ren H; Li L; Wang J; Fechner K; Guan H
J Neuroimmunol; 2019 May; 330():155-158. PubMed ID: 30904736
[TBL] [Abstract][Full Text] [Related]
6. 'Medusa head ataxia': the expanding spectrum of Purkinje cell antibodies in autoimmune cerebellar ataxia. Part 3: Anti-Yo/CDR2, anti-Nb/AP3B2, PCA-2, anti-Tr/DNER, other antibodies, diagnostic pitfalls, summary and outlook.
Jarius S; Wildemann B
J Neuroinflammation; 2015 Sep; 12():168. PubMed ID: 26377319
[TBL] [Abstract][Full Text] [Related]
7. Anti-neurochondrin antibody as a biomarker in primary autoimmune cerebellar ataxia-a case report and review of the literature.
Schwarzwald A; Salmen A; León Betancourt AX; Diem L; Hammer H; Radojewski P; Rebsamen M; Kamber N; Chan A; Hoepner R; Friedli C
Eur J Neurol; 2023 Apr; 30(4):1135-1147. PubMed ID: 36437687
[TBL] [Abstract][Full Text] [Related]
8. Autoantibodies against eukaryotic translation elongation factor 1 delta in two patients with autoimmune cerebellar ataxia.
Guo L; Ren H; Fan S; Chao X; Liu M; Guan H; Wang J
Front Immunol; 2023; 14():1289175. PubMed ID: 38332912
[TBL] [Abstract][Full Text] [Related]
9. Prevalence of Autoantibodies and the Efficacy of Immunotherapy for Autoimmune Cerebellar Ataxia.
Nanri K; Okuma M; Sato S; Yoneda M; Taguchi T; Mitoma H; Yamada J; Unezaki S; Nagatani T; Otsubo S; Sugawara M; Tanaka N; Mizusawa H
Intern Med; 2016; 55(5):449-54. PubMed ID: 26935362
[TBL] [Abstract][Full Text] [Related]
10. 'Medusa-head ataxia': the expanding spectrum of Purkinje cell antibodies in autoimmune cerebellar ataxia. Part 1: Anti-mGluR1, anti-Homer-3, anti-Sj/ITPR1 and anti-CARP VIII.
Jarius S; Wildemann B
J Neuroinflammation; 2015 Sep; 12():166. PubMed ID: 26377085
[TBL] [Abstract][Full Text] [Related]
11. Autoimmune Vestibulocerebellar Syndromes.
Narayan RN; McKeon A; Fife TD
Semin Neurol; 2020 Feb; 40(1):97-115. PubMed ID: 31958862
[TBL] [Abstract][Full Text] [Related]
12. 'Medusa head ataxia': the expanding spectrum of Purkinje cell antibodies in autoimmune cerebellar ataxia. Part 2: Anti-PKC-gamma, anti-GluR-delta2, anti-Ca/ARHGAP26 and anti-VGCC.
Jarius S; Wildemann B
J Neuroinflammation; 2015 Sep; 12():167. PubMed ID: 26377184
[TBL] [Abstract][Full Text] [Related]
13. Update in Autoimmune Movement Disorders: Newly Described Antigen Targets in Autoimmune and Paraneoplastic Cerebellar Ataxia.
Garza M; Piquet AL
Front Neurol; 2021; 12():683048. PubMed ID: 34489848
[TBL] [Abstract][Full Text] [Related]
14. Autoimmune cerebellar ataxia associated with anti-leucine-rich glioma-inactivated protein 1 antibodies: Two pediatric cases.
Weihua Z; Haitao R; Jie D; Changhong R; Ji Z; Anna Z; Hongzhi G; Xiaotun R
J Neuroimmunol; 2022 Sep; 370():577918. PubMed ID: 35853356
[TBL] [Abstract][Full Text] [Related]
15. Anti-Tr/DNER Antibody-Associated Cerebellar Ataxia: a Systematic Review.
Campana IG; Silva GD
Cerebellum; 2022 Dec; 21(6):1085-1091. PubMed ID: 34817790
[TBL] [Abstract][Full Text] [Related]
16. Acute Cerebellar Ataxia Associated with Modest Elevation of Anti-GAD Antibodies in a Young Patient.
Gomez J; Jin D
Tremor Other Hyperkinet Mov (N Y); 2018; 8():620. PubMed ID: 30647991
[TBL] [Abstract][Full Text] [Related]
17. Cerebellar ataxia and autoantibodies restricted to glutamic acid decarboxylase 67 (GAD67).
Guasp M; Solà-Valls N; Martínez-Hernández E; Gil MP; González C; Brieva L; Saiz A; Dalmau J; Graus F; Ariño H
J Neuroimmunol; 2016 Nov; 300():15-17. PubMed ID: 27806870
[TBL] [Abstract][Full Text] [Related]
18. [Usefulness of an anti-mouse cerebellar tissue-derived antigen antibody test in predicting immunotherapy efficacy in patients with idiopathic cerebellar ataxia].
Ohtomo T; Ogino S; Yanai S; Nakayama S; Yajima R; Sugawara M; Yamada J; Aizawa H; Taguchi T; Nanri K
Rinsho Shinkeigaku; 2022 Feb; 62(2):112-122. PubMed ID: 35095045
[TBL] [Abstract][Full Text] [Related]
19. Autoantibody against the Rab6A/Rab6B in primary autoimmune cerebellar ataxia associated with Sjogren's syndrome: A case report.
Guo L; Ren H; Fan S; Guan H; Wang J
J Neuroimmunol; 2021 Oct; 359():577667. PubMed ID: 34332492
[TBL] [Abstract][Full Text] [Related]
20. Inositol 1,4,5-trisphosphate receptor type 1 autoantibody (ITPR1-IgG/anti-Sj)-associated autoimmune cerebellar ataxia, encephalitis and peripheral neuropathy: review of the literature.
Jarius S; Bräuninger S; Chung HY; Geis C; Haas J; Komorowski L; Wildemann B; Roth C
J Neuroinflammation; 2022 Jul; 19(1):196. PubMed ID: 35907972
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
